Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
$9.46
+0.3%
$9.63
$9.31
$10.67
$606.54M0.51313,457 shs261,444 shs
EVAC
EQV Ventures Acquisition Corp. II
$10.27
+0.0%
$10.20
$9.90
$10.29
$599.97MN/A88,901 shs1,970 shs
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
$20.18
+1.4%
$18.86
$13.05
$21.32
$613.80M0.76126,358 shs133,480 shs
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
$8.25
+0.1%
$8.59
$8.00
$8.94
$155.79M0.3834,603 shs35,615 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
-0.32%+0.43%-2.83%-4.75%-10.61%
EVAC
EQV Ventures Acquisition Corp. II
-0.09%+0.01%+0.65%+1.09%+1,025,099,900.00%
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
+1.37%+4.23%-1.05%+11.19%+51.27%
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
-0.28%-0.76%-5.80%-3.03%+1.75%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
$9.46
+0.3%
$9.63
$9.31
$10.67
$606.54M0.51313,457 shs261,444 shs
EVAC
EQV Ventures Acquisition Corp. II
$10.27
+0.0%
$10.20
$9.90
$10.29
$599.97MN/A88,901 shs1,970 shs
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
$20.18
+1.4%
$18.86
$13.05
$21.32
$613.80M0.76126,358 shs133,480 shs
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
$8.25
+0.1%
$8.59
$8.00
$8.94
$155.79M0.3834,603 shs35,615 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
-0.32%+0.43%-2.83%-4.75%-10.61%
EVAC
EQV Ventures Acquisition Corp. II
-0.09%+0.01%+0.65%+1.09%+1,025,099,900.00%
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
+1.37%+4.23%-1.05%+11.19%+51.27%
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
-0.28%-0.76%-5.80%-3.03%+1.75%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
0.00
N/AN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
1.00
SellN/AN/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
0.00
N/AN/AN/A
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest NNY, DSU, EVAC, and HQL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/29/2026
EVAC
EQV Ventures Acquisition Corp. II
Reiterated RatingSell (D-)
(Data available from 8/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
N/AN/AN/AN/AN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
N/AN/A$0.15 per share67.26($0.28) per shareN/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/AN/AN/AN/AN/AN/A
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
$8.92MN/AN/AN/AN/AN/A-104.74%3.63%N/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
N/AN/AN/AN/AN/AN/AN/AN/AN/A

Latest NNY, DSU, EVAC, and HQL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
EVAC
EQV Ventures Acquisition Corp. II
N/A$0.07N/A$0.07N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
$1.1812.48%N/AN/AN/A
EVAC
EQV Ventures Acquisition Corp. II
N/AN/AN/AN/AN/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
$2.0410.11%N/AN/AN/A
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
$0.182.18%N/AN/A3 Years

Latest NNY, DSU, EVAC, and HQL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/5/2026
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
monthly$0.098712.28%9/15/20269/15/20269/30/2026
8/3/2026
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
monthly$0.02954.3%8/14/20268/14/20269/1/2026
6/5/2026
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
monthly$0.098712.28%8/14/20268/14/20268/31/2026
7/1/2026
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
monthly$0.02954.06%7/15/20267/15/20268/3/2026
6/5/2026
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
monthly$0.098712.32%7/15/20267/15/20267/31/2026
6/1/2026
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
monthly$0.02954.09%6/15/20266/15/20267/1/2026
5/11/2026
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
quarterly$0.5613.02%5/21/20265/21/20266/30/2026
5/11/2026
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
quarterly$0.5612.35%5/21/20265/21/20265/30/2026
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
BlackRock Debt Strategies Fund, Inc. stock logo
DSU
BlackRock Debt Strategies Fund
N/A64.15 million63.51 millionNot Optionable
EVAC
EQV Ventures Acquisition Corp. II
N/A58.45 millionN/AN/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/A30.41 million27.35 millionNot Optionable
Nuveen New York Municipal Valu stock logo
NNY
Nuveen New York Municipal Valu
N/A18.89 million18.70 millionNot Optionable

Recent News About These Companies

Nuveen New York Municipal Bond Fund;I
Nuveen New York Municipal Bond Fund;C
SPDR Nuveen ICE Municipal Bond ETF
Nuveen New York Municipal Value Inc (NNY)
How the (NNY) price action is used to our Advantage
Learn to Evaluate (NNY) using the Charts
Munis Will Continue To Rebound In 2025, Nuveen Says
(NNY) On The My Stocks Page
Nuveen NY Municipal Bond A
(NNY) Long Term Investment Analysis
How to Take Advantage of moves in (NNY)

New MarketBeat Followers Over Time

Media Sentiment Over Time

BlackRock Debt Strategies Fund stock logo

BlackRock Debt Strategies Fund NYSE:DSU

$9.46 +0.03 (+0.27%)
Closing price 03:58 PM Eastern
Extended Trading
$9.47 +0.02 (+0.20%)
As of 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BlackRock Debt Strategies Fund, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in fixed income markets of the United States. The fund primarily invests in a diversified portfolio of companies' debt instruments, including corporate loans, which are rated in the lower rating categories of the established rating services (BBB or lower by S&P's or Baa or lower by Moody's) or unrated debt instruments, which are in the judgment of the investment adviser of equivalent quality. It was formerly known as Debt Strategies Fund Inc. BlackRock Debt Strategies Fund, Inc. was formed on March 27, 1998 and is domiciled in the United States.

EQV Ventures Acquisition Corp. II NYSE:EVAC

$10.26 +0.01 (+0.05%)
Closing price 12:43 PM Eastern
Extended Trading
$10.24 -0.03 (-0.24%)
As of 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EQV Ventures Acquisition Corp II is a blank check company.

abrdn Life Sciences Investors stock logo

abrdn Life Sciences Investors NYSE:HQL

$20.18 +0.28 (+1.43%)
Closing price 03:59 PM Eastern
Extended Trading
$20.20 +0.02 (+0.10%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Nuveen New York Municipal Valu stock logo

Nuveen New York Municipal Valu NYSE:NNY

$8.25 +0.01 (+0.08%)
Closing price 03:59 PM Eastern
Extended Trading
$8.24 0.00 (-0.02%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nuveen New York Municipal Value Fund, Inc. is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New York. The fund invests in tax exempt municipal bonds, with a rating of Baa/BBB or higher. It employs fundamental analysis, with bottom-up stock picking approach, to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's New York Municipal Bond Index and Standard & Poor's National Municipal Bond Index. Nuveen New York Municipal Value Fund, Inc. was formed on October 7, 1987 and is domiciled in the United States.